Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CFC-powered inhalers inclusion in FDA reform bill agreed to by Sen. Kennedy.

This article was originally published in The Gray Sheet

Executive Summary

SEN. KENNEDY TO SUPPORT INCLUSION OF CFC-POWERED INHALERS BILLS IN S 830 during conference of the FDA reform bill. The Massachusetts Democrat is understood to be willing to accept the inclusion of Sen. Tim Hutchinson's (R-Ark.) S 1299, and its companion legislation in the House, Rep. Mark Foley's (R-Fla.) HR 2627, which would prevent FDA from banning metered-dose inhalers for asthma which use chlorofluorocarbons as the propellant until acceptable alternative products are available.



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts